Navigation Links
Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascent's Neurogenesis Platform
Date:11/4/2009

CLARKSVILLE, Md., Nov. 4 /PRNewswire/ -- Neuronascent, Inc., a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, Alzheimer's disease, Parkinson's and other neurodegenerative diseases, announces it has entered into a discovery agreement with ChemRar Pharma, a Russian biotechnology start-up company focusing on small-molecule modulators for developmental pathways and stem cells to treat cancer. Under the terms of the agreement, Neuronascent will screen certain ChemRar proprietary developmental pathway inhibitors utilizing their proprietary drug discovery platform for neurogenesis and neuroprotection. Financial terms of the collaboration were not disclosed.

The agreement matches ChemRar's discovery and translational research focus through scientific collaboration with Neuronascent's success in discovering novel, neurogenic and neuroprotective drug candidates. The companies intend to evaluate co-development opportunities for future commercialization and funding.

"We are proud to start this collaboration with ChemRar Pharma on these studies, highlighting our expertise in the field of neurogenesis, and look forward to the potential of this relationship," notes Dr. Judith Kelleher-Andersson, President and CSO, Neuronascent, Inc.

Nikolay Merkin, CBO of ChemRar Pharma, comments: "We are pleased that Neuronascent will bring high value to our R&D program and expand the scope of our molecules with their unique and well-established stem cell and neurogenesis platform. We look forward to achieving success in this collaboration."

About ChemRar Pharma:

ChemRar Pharma was established in 2007 in Moscow, Russia under the roof of the ChemRar High Tech Center as an innovative oncology start-up. In 2009, ChemRar in-licensed the portfolio of developmental pathway inhibitors from AllaChem and ChemDiv, Inc. (San Diego, CA) and established the R&
'/>"/>

SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
2. BD Announces Results for Fourth Fiscal Quarter and Full Year
3. WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
4. Mettler-Toledo International Inc. Announces Webcast of Presentation at Baird Industrial Conference
5. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
6. West Announces Third Quarter 2009 Results
7. Rigel Announces Third Quarter 2009 Financial Results
8. VIVUS Announces Promotion of Peter Tam to President
9. ATS Medical Announces Third Quarter 2009 Results
10. BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
11. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
(Date:3/26/2015)... and VANCOUVER, British Columbia, March 26, 2015 /PRNewswire/ ... provided a summary of clinical developments and announced ... Clinical Developments and Anticipated Near-term ... OncoGenex and Teva agreed to negotiate the termination ... OncoGenex. Negotiations of the final termination agreement are ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2
(Date:3/27/2015)... The Thomas Scattergood Behavioral ... foundation committed to raising its voice to improve ... , The Scattergood Foundation and The Kennedy Forum ... and Practice through the Annual Scattergood Foundation Innovation ... is designed to guide the IBS sufferer through ...
(Date:3/26/2015)... 26, 2015 Elfster.com, the top-rated Secret ... its bucket list generator capabilities to its leading Secret ... to a list that one creates of things to ... movie of the same name. Nowadays many millennials ... memorialize their summer achievements. , "We are greatly expanding ...
(Date:3/26/2015)... TX (PRWEB) March 26, 2015 ... the 32nd annual Dallas Rhinoplasty Symposium and has ... years, reiterated the importance of evidence based medicine (EBM), ... evidence from well conducted research. , "We often hear ... to rhinoplasty, and while we are certainly not trying ...
(Date:3/26/2015)... Franklin, TN (PRWEB) March 26, 2015 ... http://www.healthclick.com . This website is dedicated to providing information ... therapy and occupation therapy community. As a leader ... North American Seminars provided over 200 live and online ... PT OT continuing Education Courses :, A Master Clinicians ...
(Date:3/26/2015)... Francisco, CA (PRWEB) March 26, 2015 The ... These will be on the topics of the DAOM Program ... The DAOM Program Overview Webinar will be hosted by Dr. ... and provide the next steps on how to prepare for ... 12:30 p.m. March 25, March 27, April 1 and April ...
Breaking Medicine News(10 mins):Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2
... community outreach program in Delaware has thought of an ... ,Its “Do the Right Thing 4Life” program—supported by AIDS ... well as condoms, to people via the participating barbershops ... by Frank Hawkins, director of education and community outreach ...
... low fat diet into old age, according to a new ... study on nearly 50,000 post-menopausal women in the US, //published ... Association (JAMA), comes to the conclusion that reducing fat intake ... to maintain a stable weight. , ,This discredits ...
... weed, which contains a chemical called cannabinoids which contains a ... “high” effect on the brain. // Due to its high ... be cultivated as an indoor plant under the lamps without ... than 20 times of THC than the one cultivated 30 ...
... WinRho drug, used for treating bleeding disorders. According to Baxter ... to trigger fatal side effects, albeit rarely.// ... States since 1995, and is used to treat a bleeding ... with requisite number of platelets, to form clots. Winrho-related complications ...
... It has been known for long now that Vitamin D ... that Vitamin D supplementation in pregnant// women could lead to ... to a study it has been shown that children whose ... to have weaker bones. ,It is a common ...
... NHS could suffer a big blow if the financial condition ... the Audit Commission.// The prevalence of a weak financial management, ... by district auditors have been accounted for the present condition. ... trusts and hospitals is believed to reach ?75m by the ...
Cached Medicine News:Health News:NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey 2
... determination of Estradiol (E2) concentration in human serum ... hormone with a phenolic A ring. This ... It is the most potent natural Estrogen, ... smaller amounts by the adrenal cortex, and the ...
... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
Clinical marker immunoassay kit for detection of Myoglobin....
Medicine Products: